Case Report: Vibrio cholerae Biliary Tract Infections in Two North Africans in France.

Szczegóły
Abstrakt

Tytuł:: Case Report: Vibrio cholerae Biliary Tract Infections in Two North Africans in France.
Autorzy:: Parola P; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.; IHU-Méditerranée Infection, Marseille, France.
Anani H; IHU-Méditerranée Infection, Marseille, France.; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
Eldin C; IHU-Méditerranée Infection, Marseille, France.; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
Dubourg G; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.; IHU-Méditerranée Infection, Marseille, France.
Lagier JC; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.; IHU-Méditerranée Infection, Marseille, France.
Levasseur A; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.; IHU-Méditerranée Infection, Marseille, France.
Casalta JP; IHU-Méditerranée Infection, Marseille, France.
Raoult D; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.; IHU-Méditerranée Infection, Marseille, France.
Fournier PE; IHU-Méditerranée Infection, Marseille, France.; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
Źródło:: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2020 Jun; Vol. 102 (6), pp. 1306-1308.
Typ publikacji:: Case Reports; Journal Article
Język:: English
Imprint Name(s):: Publication: Northbrook, IL : American Society of Tropical Medicine and Hygiene
Original Publication: Baltimore.
MeSH Terms:: Biliary Tract Diseases/*microbiology
Cholera/*microbiology
Vibrio cholerae/*isolation & purification
Aged ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/therapeutic use ; Biliary Tract Diseases/drug therapy ; Cholera/drug therapy ; Cholera/pathology ; Female ; Genome, Bacterial ; Humans ; Male ; Phylogeny ; Vibrio cholerae/genetics ; Young Adult
References:: Sci Rep. 2019 May 28;9(1):7931. (PMID: 31138831)
mBio. 2016 May 03;7(3):. (PMID: 27143391)
Diagn Microbiol Infect Dis. 1998 Mar;30(3):187-91. (PMID: 9572025)
Emerg Infect Dis. 2001 Nov-Dec;7(6):1059-61. (PMID: 11747744)
Nihon Geka Hokan. 1989 Jan 1;58(1):155-61. (PMID: 2802912)
Curr Opin Infect Dis. 2018 Oct;31(5):455-461. (PMID: 30048254)
Arch Pathol Lab Med. 1982 Jun;106(6):300-1. (PMID: 6896436)
Int Microbiol. 2017 Sep;20(3):106-115. (PMID: 29446801)
Lancet. 1993 Aug 14;342(8868):431. (PMID: 8101922)
Lancet. 1967 Apr 22;1(7495):865-8. (PMID: 4164366)
Am J Gastroenterol. 1996 Oct;91(10):2241-2. (PMID: 8855762)
Bull World Health Organ. 1967;37(5):745-9. (PMID: 5300877)
Surg Endosc. 1995 Jun;9(6):730-2. (PMID: 7482176)
Trans R Soc Trop Med Hyg. 2010 Aug;104(8):563-5. (PMID: 20538311)
Substance Nomenclature:: 0 (Anti-Bacterial Agents)
Entry Date(s):: Date Created: 20200325 Date Completed: 20200814 Latest Revision: 20210602
Update Code:: 20240105
PubMed Central ID:: PMC7253139
DOI:: 10.4269/ajtmh.19-0884
PMID:: 32207400
: Czasopismo naukowe

The origin of a cholera outbreak may be unclear, as recently in Algeria. In two patients from North Africa, Vibrio cholerae was isolated in the context of hepatobiliary tract infections without any known outbreak. Gallbladder and asymptomatic long-term carriers might play a role in the emergence of cholera.

Informacja